CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2757-2765

  Schultze, Joachim L ^a,b   Michalak, Sabine ^a,b   Seamon, Mark J ^a,b   Dranoff, Glenn ^a,b   Jung, Ken ^a,b   Daley, John ^a,b   Delgado, Julio C ^a   Gribben, John G ^a,b   Nadler, Lee M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antigens, CD40; B lymphocytes; Dendritic cells; Immunotherapy, adoptive; T cell proliferation

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE ANTIGEN; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031469361     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119822     Document Type: Article

References (57)

1. Riddell, S.R., and P.D. Greenberg. 1995. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13:545-586.
2. Riddell, S.R., M.J. Gilbert, and P.D. Greenberg. 1993. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection. Curr. Opin. Immunol. 5: 484-491.
3. McKeever, D.J., and W.I. Morrison. 1994. Immunity to a parasite that transforms T lymphocytes. Curr. Opin. Immunol. 6:564-567.
4. Boon, T., J.C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
5. Celluzzi, C.M., J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific cytotoxic T lymphocyte-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
6. Paglia, P., C. Chiodoni, M. Rodolfo, and M.P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317-322.
7. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
8. Steinman, R.M., M.D. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329:1-9.
9. Inaba, K., J.P. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells as antigen presenting cells in vivo. Int. Rev. Immunol. 6:197-206.
10. Inaba, K., J.P. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
11. Metlay, J.P., E. Pure, and R.M. Steinman. 1989. Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes. Adv. Immunol. 47:45-116.
12. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba, and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-1178.
13. Rock, K.L., L. Rothstein, S. Gamble, and C. Fleischacker. 1993. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150:438-446.
14. Ke, Y., and J.A. Kapp. 1996. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells B receptor-mediated uptake. J. Exp. Med. 184:1179-1184.
15. Vidard, L., M. Kovacsovics-Bankowski, S.K. Kraeft, L.B. Chen, B. Benacerraf, and K.L. Rock. 1996. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J. Immunol. 156:2809-2818.
16. Constant, S., N. Schweitzer, J. West, P. Ranney, and K. Bottomly. 1995. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
17. Liu, Y.-J., C. Barthelemy, O. de Boutellier, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity. 2:239-248.
18. Mitchell, R.N., K.A. Barnes, S.A. Grupp, M. Sanchez, Z. Misulovin, M.C. Nussenzweig, and A.K. Abbass. 1995. Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes. J. Exp. Med. 181: 1705-1714.
19. Schultze, J.L., A.A. Cardoso, G.J. Freeman, M.J. Seamon, J. Daley, G.S. Pinkus, J.G. Gribben, and L.M. Nadler. 1995. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc. Natl. Acad. Sci. USA. 92:8200-8204.
20. Liu, K.J., V.S. Parikh, P.W. Tucker, and B.S. Kim. 1994. Surface immunoglobulins mediate efficient transport of antigen to lysosomal compartments resulting in enhanced specific antigen presentation by B cells. Eur. J. Immunol. 24:2755-2760.
21. Topalian, S.L., L. Rivoltini, M. Mancini, J. Ng, R.J. Hartzman, and S.A. Rosenberg. 1994. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer. 58:69-79.
22. Gollob, K.J., L. Nagelkerken, and R.L. Coffman. 1993. Endogenous retroviral superantigen presentation by B cells induces the development of type 1 CD4+ T helper lymphocytes. Eur. J. Immunol. 23:2565-2571.
23. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16.
24. Hsu, F.J., C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, B. Taidi, E.G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52-58.
25. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605-610.
26. Girolomoni, G., and P. Ricciardicastagnoli. 1997. Dendritic cells hold promise for immunotherapy. Immunol. Today. 18:102-104.
27. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
28. Romani, N., D. Reider, M. Heuer, S. Ebner, E. Kämpgen, B. Eibl, D. Niederwasser, and G. Schuler. 1996. Generation of mature dendritic cells from human peripheral blood. An improved method with special regard to clinical applicability. J. Immunol. Methods. 196:137-151.
29. Bender, A., M. Sapp, G. Schuler, R.M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196:121-135.
30. Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:258-261.
31. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J. Exp. Med. 182:1111-1119.
32. Szabolcs, P., M.A. Moore, and J.W. Young. 1995. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J. Immunol. 154:5851-5861.
33. Siena, S., M. Di Nicola, M. Bregni, R. Mortarini, A. Anichini, L. Lombardi, F. Ravagnani, G. Parmiani, and A.M. Gianni. 1995. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp. Hematol. 23:1463-1471.
34. Banchereau, J., and F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature. 353:678-679.
35. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 251:70-72.
36. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. Vankooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
37. Schultze, J.L., M.J. Seamon, S. Michalak, J.G. Gribben, and L.M. Nadler. 1997. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood. 89:3806-3816.
38. Visseren, M.J., A. van Elsas, E.I. van der Voort, M.E. Ressing, W.M. Kast, P.I. Schrier, and C.J. Melief. 1995. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154:3991-3998.
39. Mellado, B., D. Colomer, T. Castel, M. Munoz, E. Carballo, M. Galan, J.M. Mascaro, J.L. Vives-Corrons, J.J. Grau, and J. Estape. 1996. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J. Clin. Oncol. 14:2091-2097.
40. Pinkus, G.S., M. Lones, I.P. Shintaku, and J.W. Said. 1994. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod. Pathol 7:454-461.
41. Matzinger, P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:185-192.
42. Szabolcs, P., D. Avigan, S. Gezelter, D.H. Ciocon, M.A.S. Moore, R.M. Steinman, and J.W. Young. 1996. Dendritic cells and macrophages can mature independently from human bone marrow-derived, post-colony-forming unit intermediate. Blood. 87:4520-4530.
43. Riddell, S.R., K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:238-241.
44. Walter, E.A., P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, and S.R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
45. Heslop, H.E., C.Y. Ng, C. Li, C.A. Smith, S.K. Loftin, R.A. Krance, M.K. Brenner, and C.M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551-555.
46. Lucas, K.G., T.N. Small, G. Heller, B. Dupont, and R.J. O'Reilly. 1996. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 87:2594-2603.
47. Rooney, C.M., C.A. Smith, C.Y. Ng, S. Loftin, C. Li, R.A. Krance, M.K. Brenner, and H.E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13.
48. Papadopoulos, E.B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M.H. Carabasi, H. Castro-Malaspina, B.H. Childs, A.P. Gillio, T.N. Small, et al. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1185-1191.
49. Porter, D.L., G.J. Orloff, and J.H. Antin. 1994. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant. Transplant. Sci. 4:12-14.
50. Giralt, S.A., and H.J. Kolb. 1996. Donor lymphocyte infusions. Curr. Opin. Oncol. 8:96-102.
51. Lewalle, P., N. Hensel, A. Guimaraes, D. Couriel, Y. Jiang, Z.D. Mavroudis, and A.J. Barrett. 1996. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells. Br. J. Haematol. 92:587-594.
52. Kolb, H.J., A. Schattenberg, J.M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European group for blood and marrow transplantation working party chronic leukemia. Blood. 86:2041-2050.
53. Porter, D.L., M.S. Roth, C. McGarigle, J.L. Ferrara, and J.H. Antin. 1994. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 330:100-106.
54. Bertz, H., J.A. Berger, R. Kunzmann, R. Mertelsmann, and J. Finke. 1997. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect. Leukemia (Baltimore). 11:281-283.
55. Verdonck, L.F., H.M. Lokhorst, A.W. Dekker, H.K. Nieuwenhuis, and E.J. Petersen. 1996. Graft-versus-myeloma effect in two cases. Lancet. 347:800-801.
56. Brossart, P., A.W. Goldrath, E.A. Butz, S. Martin, and M.J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270-3276.
57. Yee, C., M.J. Gilbert, S.R. Riddell, V.G. Brichard, A. Fefer, J.A. Thompson, T. Boon, and P.D. Greenberg. 1996. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant virus. J. Immunol. 157:4079-4086.